DUDE ACCESS SERVICES DAROLUTAMIDE USER DRUG EXPERIENCE
Dead / Abandoned — Abandoned — no statement of use filed (as of 07 Sept 2020)
What this means for you
This application is over — abandoned 07 Sept 2020. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88537082
- Mark type
- Design + words
- Filed
- 25 Jul 2019
- Published for opposition
- 10 Dec 2019
- Abandoned
- 07 Sept 2020
- Attorney of record
- Christopher J. McHattie, Esq.
Goods and services
- Class 036 — Insurance and financial services: Financial administration of health reimbursement arrangements; Financial management of reimbursement payments for others; Financial administration of medication reimbursement programs and services; Financial administration of patient reimbursement programs to provide medical insurance copay assistance to eligible patients to reduce the cost; Providing patients who have been prescribed a specific course of therapy that involves prescription pharmaceuticals with information on medical insurance coverage, patient reimbursement options and financial support for that therapy; Prescription drug claims administration services, namely, facilitating authorization of health care insurance coverage, insurance claim submission and payer reimbursement for prescription drugs
Owner
- Bayer HealthCare Pharmaceuticals Inc., Whippany, NJ, US
- Bayer HealthCare Pharmaceuticals Inc., Whippany, NJ, US
Prior registrations
Prosecution history
- 08 Sept 2020 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 07 Sept 2020 — ABANDONMENT - NO USE STATEMENT FILED
- 04 Feb 2020 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 10 Dec 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 10 Dec 2019 — PUBLISHED FOR OPPOSITION
- 20 Nov 2019 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 07 Nov 2019 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 06 Nov 2019 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 06 Nov 2019 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 04 Nov 2019 — ASSIGNED TO LIE
- 28 Oct 2019 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 22 Aug 2019 — NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
- 22 Aug 2019 — EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
- 22 Aug 2019 — COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
- 22 Aug 2019 — EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED